| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/19/1998 | WO1998006380A2 Dosage form for providing ascending dose of drug |
| 02/19/1998 | WO1998006379A1 Pharmaceutical compositions |
| 02/19/1998 | WO1998006279A1 Heat-stable protein microparticles and no-shear process for producing same |
| 02/19/1998 | WO1998006266A1 Antiviral materials |
| 02/19/1998 | WO1998001124A3 Pharmaceutical preparation containing nimesulide for topical use |
| 02/19/1998 | WO1997048385A3 Controlled release tablet |
| 02/19/1998 | WO1997048382A3 Multiple-unit type prolonged action drug preparation |
| 02/19/1998 | WO1997046860A3 Improvements in detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form |
| 02/19/1998 | WO1997042979A3 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 02/19/1998 | WO1997040822A3 Delivery device |
| 02/19/1998 | WO1997039120A3 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
| 02/19/1998 | CA2263569A1 Method of producing an extruded nutritional supplement product |
| 02/19/1998 | CA2263558A1 Dosage form for providing ascending dose of drug |
| 02/19/1998 | CA2263411A1 Composition for pharmaceutical applications |
| 02/19/1998 | CA2263097A1 Homeopathic composition and process for its preparation |
| 02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
| 02/19/1998 | CA2234245A1 Tablet of isotope-labeled urea |
| 02/18/1998 | EP0824020A1 Method for manufacturing a controlled-release device |
| 02/18/1998 | EP0823996A1 Anti-infective against STD relating, for example, to HIV, Chlamydia, gonococcus, treponema pallidum or herpes simplex and device used to preserve/mix principal ingredient and base of such anti-infective |
| 02/18/1998 | EP0823993A2 PH-sensitive microcapsules |
| 02/18/1998 | EP0770381B1 Support and composition containing it together with a stabilised cosmetic or dermatologic agent |
| 02/18/1998 | EP0719148B1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 02/18/1998 | EP0695177B1 Active substance-containing plaster |
| 02/18/1998 | CN1173817A Method, compsns and kits for increasing the oral bioavilability of pharmaceuticalagents |
| 02/18/1998 | CN1173816A Oral dosage-forms containing a'beta'-lactam antibiotic |
| 02/18/1998 | CN1173815A Liposome formulations of 5'beta' steroids |
| 02/18/1998 | CN1173391A Desiccant, dehydration therewith, and dehydrated product obtainable thereby |
| 02/18/1998 | CN1173377A Multifunctional comprehensive therapeutic instrument |
| 02/18/1998 | CN1173367A Externally applied medical ointment for treating osteoproliferation |
| 02/18/1998 | CN1173356A Method for prepn. of Chinese medicinal external application ointment for diminishing inflammation, stopping pain and setting fracture |
| 02/18/1998 | CN1173353A Pills for fast growing one's height |
| 02/18/1998 | CN1173329A Health Vitamin B6 Cigarette Plaster and its prepn. method |
| 02/18/1998 | CN1173327A Production of solid drug forms |
| 02/18/1998 | CN1037406C Method for prepn. of asparagus stem extract having anti-carcinoma activity |
| 02/18/1998 | CN1037405C Spray medicinal film for gullet |
| 02/17/1998 | US5719274 Process for the preparation of low molecular weight cellulose ethers |
| 02/17/1998 | US5719197 Drug delivery |
| 02/17/1998 | US5719194 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/17/1998 | US5719131 Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
| 02/17/1998 | US5719123 Administering crystal form |
| 02/17/1998 | US5719122 Enhancing transdermal or transmucosal absorption by administering with a saturated polyglycolysed glyceride |
| 02/17/1998 | US5718923 Melt granulated sucralfate preparations and a process for their production |
| 02/17/1998 | US5718922 Intravitreal microsphere drug delivery and method of preparation |
| 02/17/1998 | US5718921 Biodegradable polymer; low temperature |
| 02/17/1998 | US5718920 Ion exchanger overcoated with permselective membrane |
| 02/17/1998 | US5718919 Nanoparticles containing the R(-)enantiomer of ibuprofen |
| 02/17/1998 | US5718917 PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
| 02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
| 02/17/1998 | US5718914 Storage means; skin transferring system; covering |
| 02/17/1998 | US5718905 Stirring a liquid phase consisting of a solution of cyclodextrin modified by acyl groups in an organic solvent with a second liquid phase essentially consisting of water |
| 02/17/1998 | US5718899 High concentration of immunoglobulins |
| 02/17/1998 | US5718865 Shaping a graunlated alum and plasticizer mixture |
| 02/17/1998 | US5718862 Secondary shaping of ionically crosslinked polymer compositions for medical devices |
| 02/17/1998 | US5718764 Apparatus for coating solid particles |
| 02/17/1998 | US5718700 Comprising drug layer (drug and polymer carrier) and push layer (osmopolymer); provides enhanced sustained release of drug overtime |
| 02/17/1998 | US5718388 Continuously feeding therapeutical or imaging agents and rigid grinding media to a milling chamber, contacting the agent with grinding media to reduce particle size, continuously removing and separating |
| 02/17/1998 | CA2080566C Pharmaceutical compositions containing triazole derivatives for rectal administration |
| 02/17/1998 | CA2030829C Insect repellent plastic |
| 02/17/1998 | CA2026516C Injectable preparations containing cephalosporin medicament |
| 02/15/1998 | CA2209540A1 Anti-infective against std relating, for example, to hiv, chlamydia, gonococcus, treponema pallidum or herpes simplex and device used to preserve/mix principal ingredient and baseof such anti-infective |
| 02/12/1998 | WO1998005688A1 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems |
| 02/12/1998 | WO1998005678A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 02/12/1998 | WO1998005434A1 Apparatus for coating foods or pharmaceuticals |
| 02/12/1998 | WO1998005360A2 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes |
| 02/12/1998 | WO1998005358A1 Sustained release preparations for injection containing gabexate mesylate |
| 02/12/1998 | WO1998005342A1 Liquid preparation comprising iron compound |
| 02/12/1998 | WO1998005334A1 Fat emulsion containing xanthine derivative |
| 02/12/1998 | WO1998005326A1 Method for treating nicotine withdrawal |
| 02/12/1998 | WO1998005325A1 Method for treating disruptive behavior disorders |
| 02/12/1998 | WO1998005324A1 Method for treating bipolar disorder |
| 02/12/1998 | WO1998005320A1 Coated trimebutine maleate tablet |
| 02/12/1998 | WO1998005312A1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| 02/12/1998 | WO1998005310A1 Capsules for oral preparations and capsule preparations for oral administration |
| 02/12/1998 | WO1998005309A1 Cyclosporin formulation |
| 02/12/1998 | WO1998005308A2 Terazosin capsules |
| 02/12/1998 | WO1998005306A1 Controlled release tablet formulation of isosorbide-5-mononitrate |
| 02/12/1998 | WO1998005305A1 Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient |
| 02/12/1998 | WO1998005304A1 Biocompatible devices with foam scaffolds |
| 02/12/1998 | WO1998005303A1 Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs |
| 02/12/1998 | WO1998005302A1 Aerosol formulations |
| 02/12/1998 | WO1998005301A1 Multiple emulsions comprising a hydrophobic continuous phase |
| 02/12/1998 | WO1998005300A2 Delivery system for pharmaceutical agents encapsulated with oils |
| 02/12/1998 | WO1998005294A1 An oil-in-water emulsion for use on human skin for cleansing, preserving or improving the condition of the skin |
| 02/12/1998 | WO1998005207A1 Method for treating excessive aggression |
| 02/12/1998 | WO1997038662A3 Buccal polar spray or capsule |
| 02/12/1998 | DE19649730A1 Health product containing minerals and vitamin(s) particularly for smokers |
| 02/12/1998 | CA2262614A1 Method for treating disruptive behavior disorders |
| 02/12/1998 | CA2262578A1 Fat emulsion containing xanthine derivative |
| 02/12/1998 | CA2261946A1 Method for treating nicotine withdrawal |
| 02/12/1998 | CA2261676A1 Method for treating excessive aggression |
| 02/11/1998 | EP0823439A1 Improvements in or relating to agglomeration of starch |
| 02/11/1998 | EP0823255A1 Pharmaceutical composition containing sucralfate |
| 02/11/1998 | EP0822857A1 Novel artificial pancreas |
| 02/11/1998 | EP0822847A2 Composition and method of enhancing electrotransport agent delivery |
| 02/11/1998 | EP0822824A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel |
| 02/11/1998 | EP0822822A1 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 02/11/1998 | EP0822819A1 Solvent detergent emulsions having antiviral activity |
| 02/11/1998 | EP0822810A1 Tamper evident pharmaceutical dosage form |
| 02/11/1998 | EP0822809A1 Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| 02/11/1998 | EP0822808A2 Composite with sodium starch glycolate as a support material and products thereof |